Review Article
Clinical Trials and Treatment of ATL
Table 1
Results of sequential chemotherapeutic-trials of untreated patients with ATL (JCOG-LSG).
| | J7801 | J8101 | J8701 | J9109 | J9303 | JCOG9801 | | LSG1 | LSG1/LSG2 | LSG4 | LSG11 | LSG15 | mLSG15/mLSG19 |
| | Pts. No. | 18 | 54 | 43 | 62 | 96 | 57 | 61 | | CR (%) | 16.7 | 27.8 | 41.9 | 28.3 | 35.5 | 40.4 | 24.6 | | CR + PR (%) | | | | 51.6 | 80.6 | 72.0 | 65.6 | | MST (months) | | 7.5 | 8.0 | 7.4 | 13.0 | 12.7 | 10.9 | | 2 yr. survival (%) | | | | 17.0 | 31.3 | | | | 3 yr. survival (%) | | | | 10.0 | 21.9 | 23.6 | 12.7 | | 4 yr. survival (%) | | 8.0 | 11.6 | | | | |
|
|
CR: complete remission, PR: partial remission, MST: median survival time.
|
